Enzyme inhibition, radical scavenging, and spectroscopic studies of vanadium(IV)–hydrazide complexes

Vanadium Compounds with Antidiabetic Potential

Over the last four decades, vanadium compounds have been extensively studied as potential antidiabetic drugs. With the present review, we aim at presenting a general overview of the most promising compounds and the main results obtained with in vivo studies, reported from 1899-2023. The chemistry of vanadium is explored, discussing the importance of the structure and biochemistry of vanadate and the impact of its similarity with phosphate on the antidiabetic effect. The spectroscopic characterization of vanadium compounds is discussed, particularly magnetic resonance methodologies, emphasizing its relevance for understanding species activity, speciation, and interaction with biological membranes. Finally, the most relevant studies regarding the use of vanadium compounds to treat diabetes are summarized, considering both animal models and human clinical trials. An overview of the main hypotheses explaining the biological activity of these compounds is presented, particularly the most accepted pathway involving vanadium interaction with phosphatase and kinase enzymes involved in the insulin signaling cascade. From our point of view, the major discoveries regarding the pharmacological action of this family of compounds are not yet fully understood. Thus, we still believe that vanadium presents the potential to help in metabolic control and the clinical management of diabetes, either as an insulin-like drug or as an insulin adjuvant. We look forward to the next forty years of research in this field, aiming to discover a vanadium compound with the desired therapeutic properties.

Therapeutic Properties of Vanadium Complexes

Vanadium is a hard, silver-grey transition metal found in at least 60 minerals and fossil fuel deposits. Its oxide and other vanadium salts are toxic to humans, but the toxic effects depend on the vanadium form, dose, exposure duration, and route of intoxication. Vanadium is used by some life forms as an active center in enzymes, such as the vanadium bromoperoxidase of ocean algae and nitrogenases of bacteria. The structure and biochemistry of vanadate resemble those of phosphate, hence vanadate can be regarded as a phosphate competitor in a variety of biochemical enzymes such as kinases and phosphatases. In this review, we describe the biochemical pathways regulated by vanadium compounds and their potential therapeutic benefits for a range of disorders including type 2 diabetes, cancer, cardiovascular disease, and microbial pathology.

A series of organic hybrid polyoxovanadate clusters incorporating tris(hydroxymethyl)methane derivatives

A series of new organic hybrid polyoxovanadate clusters [V₄O₄(μ-OH)₂(acac)₂(Htri)₂] (1, H₃tri = tris(hydroxymethyl) aminomethane, acac = acetylacetone), [V₄O₄(acac)₂(Htri)₂(L)₂] {HL = methanol (2), ethanol (3a and 3b), ethylene glycol (4) and benzyl alcohol (5)}, {V₄O₄(H₂O)₂(tri-acetamide)₂(CH₃COO)₂} (6, H₃tri-acetamide = N-(2-hydroxy-1,1-bis-hydroxymethyl-ethyl)-acetamide), [V₆O₈(μ-OH)₂(Htri)₃]·6H₂O (7) and [V₁₄O₁₈(tri)₂(Htri)₆(HCOO)(CH₃COO)]·2H₂O (8) were prepared by hydro(solvo)thermal methods and characterized structurally. 1 contains [VO(OH)(acac)] and [VO₂(Htri)] units, which are further interconnected via common edges to build a tetravanadyl cluster [V₄O₄(OH)₂(acac)₂(Htri)₂] with the double-deficient cube [V₄O₆]. The tetravanadyl cluster frameworks of 2-5 can be derived from the tetravanadyl cluster of 1 by replacing two -OH groups with two deprotonated organic alcohol ligands, namely, CH₃O^- (2), CH₃CH₂O^- (3a and 3b), HO(CH₂)₂O^- (4) and C₆H₅CH₂O^- (5). Interestingly, both 3a and 3b have the same chemical structure, but they exhibit different conformational polymorphisms [denoted as α-type (3a) and β-type (3b)]. Such conformational polymorphisms within the polyoxovanadate clusters incorporating tris(hydroxymethyl)methane derivatives emerged for the first time. 6 displays another tetravanadyl cluster {V₄O₄(H₂O)₂(tri-acetamide)₂(CH₃COO)₂} with a [V₄O₁₆] fragment, where the tri-acetamide unit comes from the amidation reaction of H₃tri and acetic acid and caps the tetrahedral void of the tetravanadyl cluster. The polyoxovanadate cluster of 7 can originate from the Lindqvist-type hexavanadyl cluster [V₆O₁₉] by replacing nine μ-oxides with nine alkoxides of three tri-acetamide^3- ligands. 8 exhibits a fully reduced tetradecavanadyl cluster based on the linkage of two heptavanadyl clusters via two O bridges. The magnetic properties of 1-8 show typical antiferromagnetic interactions.

In Vitro Synthesis, Structure elucidation and its antioxidant properties of Platinum(IV)-hydrazide complexes: Molecular modeling of free-hydrazides suggested as potent lipoxygenase inhibitor

BACKGROUND

Combination of biologically active ligand and metal in one molecule may increase the activity and reduce the toxicity.

OBJECTIVES

In this study synthesis and characterization of platinum(IV) complexes with bioactive hydrazide ligands is discussed.

METHOD

Elemental analysis, conductivity measurements and spectroscopic studies were used to elucidate the structure of complexes.

RESULTS

Our study suggests that hydrazide ligands coordinate with Pt(IV) in bidenate fashion. The platinum(IV) complexes have octahedral geometry with metal to ligand ratio of 1:2. Hydrazide ligands coordinated with central metal platinum(IV) by oxygen of carbonyl group and nitrogen of primary amine. Synthesized complexes exhibited variable DPPH radical scavenging and lipoxygenase inhibition activity. Furthermore, it is also found that Pt(IV)-hydrazide complexes are more potent superoxide and nitric oxide radical scavengers than their uncoordinated hydrazide ligands while in case of lipoxygenase enzyme inhibition, some of the free hydrazide ligands are more active than their respective Pt(IV) complexes. In silico docking technique explores molecular interactions of synthesized ligands in the active site of lipoxygenase enzyme. Predicted docking energies are in good agreement with experimental data suggesting that in silico studies might be useful for discovery of therapeutic candidates.

CONCLUSION

Structure function relationship demonstrates that the radical scavenging and enzyme inhibition activities of the Pt(IV) compounds are effected by nature of ligand, position of substituent, electronic and steric effects. However, electronic factor seem to play more important role than other factors.

Chemistry, Alpha-glucosidase and Radical Scavenging Properties of Uranyl(VI) Hydrazide Complexes

BACKGROUND

Antioxidant, anti-inflammatory, antiviral and antitumoral activities among others are essential characteristics in the development of novel therapeutic compounds. Acid hydrazides can form complexation with certain metal ions that positively enhance these biological characteristics.

OBJECTIVE

Five new complexes of uranium with hydrazide ligands were synthesized at room temperature.

METHODS

The characterization was done by spectroscopic methods (ESI-Mass, IR, 1H-NMR, 13CNMR), CHN analysis and conductivity measurements. Metal complexes along with their respective ligands were further screened for their antioxidant (DPPH, superoxide and nitric oxide free radicals) properties and enzyme inhibition (α-glucosidase) activities.

RESULTS

Elemental and spectral data indicate octahedral geometry around uranyl (UO2 2+) species. Magnetic moments indicate the diamagnetic nature of uranyl(VI) ion in the complex in solid state. IC50 values showed potential antioxidant behavior of uranyl complexes demonstrating interesting structure-activity relationships. In general, hydrazide ligands were not active against superoxide and nitric oxide radicals while varying degree of results were observed against DPPH radical whereas all uranyl-complexes showed promising radical scavenging activities against all of them. Promising inhibitory potential was displayed by UO2 +2 hydrazide complexes against α- glucosidases whereas free hydrazide ligands were inactive.

CONCLUSION

Structure function relationship demonstrates that the nature of ligand, position of substituent, electronic and steric effects are significant factors affecting the radical scavenging and enzyme inhibition activities of the compounds.

Antidiabetic effect of an extract of nutricultured Brassica napus containing vanadium from a Jeju water concentrate

The purpose of this study was to determine the antidiabetic effect of an extract of nutricultured Brassica napus containing vanadium (BECV). The BECV was prepared following nutriculture of B. napus with a Jeju water vanadium concentrate for 7 day. The BECV was administered to db/db mice for 8 weeks at different dosages (0.028, 0.14, and 0.7 μg/kg; as vanadium concentration in BECV). After 8 weeks, the BECV results showed mouse blood glucose concentrations to significantly decrease, in a dose-dependent manner, compared with the results for control mice. In addition, the concentrations of triglyceride, total cholesterol, and glycated hemoglobin were significantly lower after 8 weeks of administration of 0.7 μg/kg BECV. Therefore, the BECV may have protective effects against type 2 diabetes.

Vanadium(V) complexes with hydrazides and their spectroscopic and biological properties

The present study explores the synthesis and inhibitory potential of vanadium(V) complexes of hydrazides (1c-12c) against oxidative enzymes including xanthine oxidase and lipoxygenase (LOX). In addition, non-enzymatic radical scavenging activities of these complexes were also determined. On the basis of spectral, elemental and physical data, synthesized vanadium(V) complexes are tentatively assigned to have an octahedral geometry with two hydrazide ligands and two oxo groups forming a negatively charged sphere complex with ammonium as counter ion. This is further verified by the conductivity studies of the complexes. Results show that hydrazide ligands (1-12) and their respective vanadium(V) complexes (1c-12c) posses scavenging and inhibition potential against DPPH and LOX, respectively. However, contrary to that uncoordinated ligands showed no activity against nitric oxide, superoxide and xanthine oxidase whereas their complexes showed varying degree of activity. These studies indicate that geometry of complex, nature and position of substituent groups play a vital role in scavenging and inhibition potential of these compounds.

Synthesis, spectroscopic and radical scavenging studies of palladium(II)-hydrazide complexes

In present study, a series of palladium(II) complexes with biologically active hydrazide ligands have been synthesized, characterized and screened for their antioxidant (superoxide and DPPH radical scavenging) properties. Spectral studies (FT-IR, EI-mass, (13)C and (1)H NMR spectroscopy) and physico-chemical measurements including elemental analysis, magnetic susceptibility and conductivity measurements represented square planar structure for all complexes. Substituted and unsubstituted benzohydrazides (1-4) have shown monodentate behavior forming complexes of general formula [PdL2Cl2]. However, pyridinecarbohydrazides (5 and 6) were coordinated in bidentate fashion of [PdLCl2] general formula producing stable five-membered chelate ring. All palladium complexes were found to be considerably more potent inhibitors of DPPH free radical compared to free hydrazides. These complexes are even stronger DPPH scavengers than standard antioxidant propyl gallate. The complexes have also shown good superoxide scavenging ability compared to inactive free hydrazides, however complexes are weaker superoxide scavengers than ascorbic acid, a standard superoxide inhibitor. An interesting structure activity relationship has been evaluated.